December 01, 2017
In a report released November 28, 2017, the World Health Organization revealed that an estimated "1 in 10 medical products circulating in low- and middle-income countries is either substandard or falsified." Furthermore, the findings detailed that there is an estimated 10.5% failure rate in all medical products used in low- and middle-income countries. Kenneth McCall, BSPharm, Pharm.D., CGP, associate professor for the Department of Pharmacy Practice, weighed in as an expert on the topic, discussing the implications of this failure rate with NPR.
“A 10.5 percent failure rate on medical products is unacceptable anywhere in the world. And that threat is growing, not diminishing, because it is a huge underground industry, a very profitable criminal industry that is even threatening our secure drug supply chain in the United States," McCall said.
McCall, who is on the board of directors for the Partnership for Safe Medicines (PSM), works with the organization to protect consumers against against counterfeit, substandard or otherwise unsafe medicines. Recently, the group connected dangerous counterfeit pain medications laced with fentanyl, which is 50 times more powerful than heroin, to deaths in 12 U.S. states.
"We know that it's contributing to the opioid crisis in the United States," says McCall.
To learn more about the University of New England’s College of Pharmacy, visit www.une.edu/pharmacy
To apply, visit www.une.edu/admissions